CSIMarket Company Name, Ticker, Industry, else..
 
Exagen Inc   (NASDAQ: XGN)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare
 
Price: $6.9700 $-0.34 -4.651%
Day's High: $7.340000152587891 Week Perf: -7.56 %
Day's Low: $ 6.83 30 Day Perf: 2.5 %
Volume (M): 197,460 52 Wk High: $ 12.23
Volume (M$): $ 0 52 Wk Avg: $5.93
Open: $7.26 52 Wk Low: $2.59



 Market Capitalization (Millions $) 168
 Shares Outstanding (Millions) 24
 Employees 220
 Revenues (TTM) (Millions $) 71
 Net Income (TTM) (Millions $) 4
 Cash Flow (TTM) (Millions $) -9
 Capital Exp. (TTM) (Millions $) 1

Business Description


Exagen Inc is a biotechnology company that specializes in developing and commercializing diagnostic tests for autoimmune diseases. The company focuses on leveraging advanced testing technologies and genomics to provide personalized medicine solutions for patients with complex autoimmune conditions. Exagen's tests help physicians in accurately diagnosing and monitoring patients, allowing for targeted treatment plans and improved disease management. Some of the diseases that Exagen's tests detect and monitor include lupus, rheumatoid arthritis, and autoimmune-related kidney diseases. The company aims to enhance patient outcomes and contribute to the advancement of precision medicine in the field of autoimmune diseases.


   Company Address: 1261 Liberty Way Vista, 92081 CA
   Company Phone Number: 560-1501   Stock Exchange / Ticker: NASDAQ XGN


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
DGX   -4.01%    
FCHS      0% 
ISPC        0.67% 
MYGN        4.02% 
OPK   -11.83%    
• View Complete Report
   



Shares

Exagen Inc Strengthens Financial Position Amidst Share Sale and Credit Facility: A Proactive Strategic Maneuver to Bolster Shareholder Value

Published Fri, May 9 2025 8:05 PM UTC

Exagen Inc. Strengthens Financial Position Amidst Share Sale and Credit Facility: A Proactive Strategic Maneuver to Bolster Shareholder ValueIn a noteworthy development, Exagen Inc. (Nasdaq: XGN), a pioneering entity in the realm of autoimmune diagnostics, has successfully orchestrated the sale of an additional 502,500 shares of its common stock. This transaction was conduct...
Product Service News

Exagen Inc. Navigating the High Seas of Autoimmune Diagnostics Amidst Market Challenges

Published Thu, Nov 14 2024 9:30 PM UTC

In a significant development in the field of autoimmune disease diagnostics, Exagen Inc. recently announced the successful validation and regulatory submission for new biomarkers related to lupus and rheumatoid arthritis. This breakthrough comes through their innovative AVISE CTD platform, designed to enhance diagnostic clarity for clinicians treating patients plagued by the...



Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 2.36
Price to Sales (Expected) -
Price to Book 13.79
PEG (TTM) -

Financial Strength Current
Quick Ratio 1.83
Working Capital Ratio 3.19
Leverage Ratio (MRQ) 3.25
Total Debt to Equity 1.91
Interest Coverage (TTM) -
Debt Coverage (TTM) 0.49

Per Share Current
Earnings (TTM) -0.83 $
Revenues (TTM) 2.96 $
Cash Flow (TTM) -
Cash 1.02 $
Book Value 0.51 $
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) 324,668
Net Income per Employee (TTM) 16,827
Receivable Turnover Ratio (TTM) 5.7
Inventory Turnover Ratio (TTM) -
Asset Turnover Ratio (TTM) 1.27

Profitability Ratios Current
Gross Margin (MRQ) 61.27 %
Operating Margin (MRQ) -8.64 %
Net Margin (MRQ) 0 %
Net Cash Flow Margin (MRQ) 0 %
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) 6.59 %
Return On Investment (TTM) 8.63 %
Return On Equity (TTM) 23.79 %
Dividend Yield -
Pay out Ratio (TTM) -



Exagen Inc's Segments
Reportable    186.79 % of total Revenue





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.